Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVC-LVS vs USAMRIID-LVS for Tularemia
NCT01150695Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2010
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NDBR 101 in tularemia, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2010; status: completed.
02
Drugs
NDBR 101
03
Conditions
tularemia
Beyond the preview
Go deeper on NCT01150695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150695.